TORONTO, May 29, 2024
/CNW/ - CareRx Corporation ("CareRx" or the
"Company") (TSX: CRRX), Canada's leading provider of pharmacy services
to seniors living and other congregate care communities, today
announced that as part of the Company's commitment to Board
refreshment and to realign Board functions to match the Company's
strategic focus on operational performance, Kevin Dalton, Chairman of the Board for the last
six years, will be retiring as Chairman effectively immediately.
Mr. Dalton will be succeeded by Jeff
Watson, a current independent director of the
Board. Mr. Dalton will be stepping into the role as Chair of
the Compensation, Nominating and Governance Committee in place of
Maria Perrella, who will continue to
remain Chair of the Audit Committee.
Mr. Watson said, "We would like to express our deep appreciation
to Kevin for his outstanding contributions to CareRx during his
tenure as Chairman, and his exceptional stewardship during these
recent years of growth and transformation. We look forward to
continuing to receive his guidance and support as a fellow Board
member. With the Company's performance culture and focus on
operational excellence, we are excited for the next chapter."
Mr. Dalton said, "Serving as CareRx's Chairman has been an
honour. We have an enthusiastic management team with fresh
leadership under Puneet Khanna, and
with Jeff transitioning to Chairman I am confident that this team
will continue to execute on the Company's strategic vision and
plans. I look forward to continuing to work with management and my
fellow Board members to enhance value for all of our
shareholders."
Mr. Watson has served on the Board of CareRx since 2023 and
brings over three decades of experience in the healthcare industry,
having most recently served as the President and CEO of Apotex from
2018 to 2023. Mr. Watson currently represents SK Capital Partners
on two of their portfolio company boards for Apotex and Woodstock
Sterile Solutions, and has previously served on numerous other
boards, including as a board member and Chair of the Association
for Accessible Medicines (AAM), Chair of the Canadian Generic
Pharmaceutical Association (CGPA), and former Chair of the US
Healthcare Distribution Alliance's (HDA) knowledge partner, the HDA
Research Foundation.
The Company also announced that the nominees listed in the
Management Information Circular for the Annual General Meeting of
Shareholders (the "Meeting"), which was held on May 29, 2024, were elected as directors of the
Company. In addition, all other resolutions put to vote at the
Meeting were passed.
The results of the vote for the election of directors at the
Meeting are as follows:
Nominees
|
Votes
For
|
Kevin Dalton
|
34,798,054
(99.136 %)
|
Ralph
Desando
|
34,626,285
(98.647 %)
|
Puneet
Khanna
|
34,817,837
(99.193 %)
|
Keith
McIntosh
|
34,679,144
(98.797 %)
|
Bruce Moody
|
34,653,016
(98.723 %)
|
Maria
Perrella
|
34,832,002
(99.233 %)
|
Jeff Watson
|
35,002,450
(99.719 %)
|
About CareRx Corporation
CareRx is Canada's leading
provider of pharmacy services to seniors living communities. We
serve approximately 91,000 residents in over 1,500 seniors and
other congregate care communities (long-term care homes, retirement
homes, assisted living facilities, and group homes). We are a
national organization with a large network of pharmacy fulfillment
centres strategically located across the country. This allows us to
deliver medications in a timely and cost-effective manner and
quickly respond to routine changes in medication management. We use
best-in-class technology that automates the preparation and
verification of multi-dose compliance packaging of medication,
providing the highest levels of safety and adherence for
individuals with complex medication regimens. We take an active
role in working with our home operator partners to promote resident
health, staff education, and medication system quality and
efficiency.
SOURCE CareRX Corporation